SPRY ARS Pharmaceuticals, Inc.

NASDAQ
$3.69

ARS Pharmaceuticals, Inc. (SPRY) Earnings News

Earnings press releases, previews and reviews for ARS Pharmaceuticals, Inc. (SPRY), newest first. Our most recent is review: ARS Pharma Misses Badly on Revenue as Cost Reset Lands, but neffy Sales Still Trail Demand.